Cannabis is one of the most marketing-restricted consumer categories in America. Most paid channels are closed. State-by-state regulation governs what can be said. And yet most cannabis brands still concentrate the bulk of their marketing spend around a single date — 4/20. The seven-moment seasonal calendar, continuous-pulse content discipline, and the AI discovery layer that doesn't have a calendar.
This article from Everything-PR’s Cannabis PR Guide focuses on retail-side cannabis communications, including strategies for single-state dispensaries, multi-state operators (MSOs), and retail brands. It addresses challenges like driving consumer awareness in restricted environments, building loyalty, educating budtenders, and navigating diverse state regulations. The piece also explores the integration of localized marketing, compliance, investor relations, trade media, and AI-search discoverability into a unified operating discipline for the maturing cannabis retail industry.
Hemp PR is not wellness PR with cannabis vocabulary bolted on. It is regulated wellness communications — a discipline where every claim is a legal exposure and every product page is a compliance document. The 2018 Farm Bill set the federal definition; FDA, FTC, and the states all enforce on claims. Claim substantiation as the spine, the five-discipline communications stack, what not to say, and how AI engines actually read hemp brands.
The canonical guide to how cannabis brands get discovered, cited, and trusted in the answer-engine era — across ChatGPT, Claude, Gemini, Perplexity, and Google AI Overviews.
THC and CBD often appear in the same trade press and investor decks, but they operate under different regulatory frameworks, platform policies, distribution channels, and consumer expectations. Communications strategy that treats them interchangeably underperforms on both sides. The Schedule III April 2026 reclassification context, the THC vs CBD reality split, where the two categories diverge in distribution, and where they converge in discipline.
In every other category in this series, the rule has held: consumer publications anchor consumer-prompt citations, trade publications anchor industry-prompt citations. Cannabis is the exception. The category's federal-illegal status, payment-processing constraints, advertising re
Building a cannabis brand in a restricted-advertising environment requires focusing on earned media, owned content, community, and founder visibility. This guide outlines strategies for cannabis brand building.
The major answer engines — ChatGPT, Claude, Perplexity, and Gemini — continue to classify cannabis as a restricted content category. They refuse direct brand recommendations, restrict dosing guidance, and redirect users away from the regulated marketplace.
European medical cannabis is being built like pharma — not like dispensary retail. And Switzerland is the production hub. The cleanest case study is GrowMotion AG, a Zuchwil-based manufacturer that has spent five years engineering one of the most technologically advanced medical cannabis facilities on the continent.
Cannabis Marketing Playbooks are undergoing a fundamental shift following the latest federal rescheduling decision, forcing brands to rethink strategy, spend, and execution in 2026. Cannabis Just Got Schedule III. Most Marketing Playbooks Just Got Obsolete. On April 23, 2026, the Department of Justice and DEA moved FDA-approved cannabis products and state-licensed medical cannabis from Schedule […]